Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism
- 1 April 1987
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 11 (2) , 252-257
- https://doi.org/10.1007/bf01656411
Abstract
No abstract availableFunding Information
- National Institutes of Health (RR30)
This publication has 47 references indexed in Scilit:
- Long-term Evaluation of Patients with Primary Parathyroid Hyperplasia Managed by Total Parathyroidectomy and Heterotopic AutotransplantationAnnals of Surgery, 1980
- Morphological, Functional and Immunological State of the Gastric Mucosa in Gastric Carcinoma FamiliesScandinavian Journal of Gastroenterology, 1979
- Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor. Report of a case and review of the literatureCancer, 1978
- Provocative Agents and the Diagnosis of Medullary Carcinoma of the Thyroid GlandAnnals of Surgery, 1978
- Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.Gut, 1977
- Occurrence of other endocrine tumours in primary hyperparathyroidismThe Lancet, 1975
- A reappraisal of the nature and significance of chronic atrophic gastritisDigestive Diseases and Sciences, 1973
- Gastrin, Age and the Gastric Mucosa*Australian and New Zealand Journal of Medicine, 1973
- HyperparathyroidismAnnals of Surgery, 1972
- STUDY OF A KINDRED WITH PHEOCHROMOCYTOMA, MEDULLARY THYROID CARCINOMA, HYPERPARATHYROIDISM AND GUSHING ʼS DISEASE: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 21Medicine, 1968